Medical Procedure News

RSS

McGill researchers pioneer anesthetics via videoconferencing

Videoconferences may be known for putting people to sleep, but never like this. Dr. Thomas Hemmerling and his team of McGill's Department of Anesthesia achieved a world first on August 30, 2010, when they treated patients undergoing thyroid gland surgery in Italy remotely from Montreal. The approach is part of new technological advancements, known as 'Teleanesthesia', and it involves a team of engineers, researchers and anesthesiologists who will ultimately apply the drugs intravenously which are then controlled remotely through an automated system.

10 Sep 2010

SurgiCount Medical to implement Safety-Sponge System at Kalispell Regional Medical Center

SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc., today announced that it has signed a contract with Kalispell Regional Medical Center to implement the SurgiCount Safety-Sponge® System, a proven solution to prevent one of the most common surgical errors, retained surgical sponges.

10 Sep 2010

Nucletron to present innovative cancer treatment during ESTRO29

Nucletron, a leading provider of state of the art radiotherapy solutions for cancer treatment, today announced a large number of exciting innovations for precise cancer treatment that will be in the spotlight during ESTRO29 in Barcelona. The company will be showcasing the latest developments in cancer treatment solutions for both brachytherapy and external beam.

10 Sep 2010

Avinger initiates enrollment in Wildcat Catheter trial for chronic total occlusions in femoropopliteal lesions

Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announces the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. The CONNECT trial is a prospective, multi-center, non-randomized study intended to evaluate the Wildcat Catheter's ability to cross chronic total occlusions in femoropopliteal lesions.

10 Sep 2010

Tornier pyrocarbon shoulder prostheses reduce patient pain, offered shorter recovery time

Tornier, Inc., a global leader in extremity and sports medicine orthopaedics, announced today the successful early clinical results of the first seven pyrocarbon shoulder prostheses that were implanted between April 2009 and December 2009.

10 Sep 2010

AAOS releases clinical practice guideline for periprosthetic joint infection diagnosis

The American Academy of Orthopaedic Surgeons (AAOS) recently approved and released an evidence-based clinical practice guideline on the diagnosis of periprosthetic joint infections of the hip and knee. Clinical practice guidelines are one avenue the Academy uses to ensure that patients receive high quality care.

10 Sep 2010

USPTO issues patent for Advaxis’ live Listeria HER2/neu immunotherapy

The U.S. Patent and Trademark Office has issued to Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, patent number 7,784,729 titled "Methods and Compositions for Immunotherapy of Cancer," based upon patent application 10/949,667.

10 Sep 2010

Mayo Clinic opens newly expanded neurophysiology laboratory at Florida campus

Mayo Clinic unveiled a newly expanded, state-of-the-art neurophysiology laboratory on its Florida campus to provide additional services and care for more patients, many of whom are referred by community physicians for specialized diagnostic testing.

10 Sep 2010

VAP Cholesterol Test can evaluate Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome, known as PCOS, is a silent and often mysterious disease that plays havoc with a woman's body and increases the risk of serious illness. There is no single test for diagnosing the illness, but a detailed cholesterol profile called the VAP Cholesterol Test, along with diet, exercise and the right medication, is changing how doctors approach PCOS and is dramatically altering patients' lives for the better.

10 Sep 2010

ESC recommends InspireMD MGuard mesh technology for thrombotic lesions

InspireMD Ltd., a medical device company engaged in the development and commercialization of the mesh based MGuard(TM) stent systems, is proud to report that mesh-based protection, is now recommended for use in the new Guidelines of the Task force of Myocardial Revascularization of the European Society of Cardiology (ESC). According to the latest European Society of Cardiology Guidelines, published at the ESC Congress last week, "Mesh-based protection may be considered for PCI of highly thrombotic or SVG lesions" - it has received a class IIb recommendation.

9 Sep 2010

Experts examine impact of two cardiac rescue strategies: chest compressions first vs. defibrillation first

Chest compressions before defibrillation in patients with sudden cardiac arrest is equally successful as immediate treatment with an electrical defibrillator, according to a new study by the University of Michigan Health System.

9 Sep 2010

Hormone treatment with chemotherapy results in deadly side-effect in neuroblastoma children

Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.

9 Sep 2010

'Beach envy' triggers enquiries for liposuction

The Harley Medical Group has reported thousands of enquiries for liposuction over the last month as a wave of what is termed 'beach envy' - jealousy of other women's bodies - hit holidaymakers.

9 Sep 2010

BioMimetic completes 100 day PMA meeting with FDA for Augment Bone Graft

BioMimetic Therapeutics, Inc. today announced it completed its 100 day Premarket Approval Application (PMA) meeting with the Food and Drug Administration (FDA) regarding the review of Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S. The FDA generally meets with the PMA sponsor approximately 100 days after the filing of the PMA with the purpose of discussing the status of the application.

9 Sep 2010

BC gynecologists initiate campaign to reduce ovarian cancer mortality

Gynecologic oncologists with the Ovarian Cancer Research Program at Vancouver General Hospital (VGH) and the BC Cancer Agency have begun an important campaign that will reduce deaths from ovarian cancer.

9 Sep 2010

Scientists identify molecular marker to analyze chemotherapy response in breast cancer patients

A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.

9 Sep 2010

Non-invasive test using patient's breath can detect cancer

A test using a patient's breath could be developed to detect lung, breast, bowel and prostate cancers, a team of scientists have discovered.While these results are only preliminary, the study published in the British Journal of Cancer today (Wednesday), found that sensors could distinguish between the breath of healthy patients and those who have cancer.

9 Sep 2010

Patients expects good long-term solutions for artificial hip system: Report

In response to the news that DePuy Orthopaedics, the manufacturer of an artificial hip system, issued a recall of its ASR product line after data indicated a higher than expected need for device replacement surgery five years after the initial procedure, Dr. Eugene S. Krauss, chairman of the Department of Orthopedics and director of the Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member of the North Shore-LIJ Health System, states,This news should not alarm anyone who has had their joint replacement performed at The Center for Joint Replacements at Glen Cove Hospital, Southside Hospital, or Peconic Bay Medical Center, as we are not using any of these components.

9 Sep 2010

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

Competitive Technologies, Inc. announced today the publication of the detailed results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTTC's Calmare® Pain Therapy Treatment

9 Sep 2010

Spirus Medical obtains Japanese marketing approval for ENDO-EASE line of endoscopy devices

Spirus Medical announced today that it has obtained marketing approval from the Japanese Ministry of Health, Labor and Welfare for the company's proprietary ENDO-EASE line of endoscopy devices. The Endo-Ease Endoluminal Advancement System features novel "over-tubes" that use a spiral design utilizing simple rotation to facilitate enteroscopy, colonoscopy and ileoscopy.

9 Sep 2010

Medical Procedure News

McGill researchers pioneer anesthetics via videoconferencing

SurgiCount Medical to implement Safety-Sponge System at Kalispell Regional Medical Center

Nucletron to present innovative cancer treatment during ESTRO29

Avinger initiates enrollment in Wildcat Catheter trial for chronic total occlusions in femoropopliteal lesions

Tornier pyrocarbon shoulder prostheses reduce patient pain, offered shorter recovery time

AAOS releases clinical practice guideline for periprosthetic joint infection diagnosis

USPTO issues patent for Advaxis’ live Listeria HER2/neu immunotherapy

Mayo Clinic opens newly expanded neurophysiology laboratory at Florida campus

VAP Cholesterol Test can evaluate Polycystic Ovarian Syndrome

ESC recommends InspireMD MGuard mesh technology for thrombotic lesions

Experts examine impact of two cardiac rescue strategies: chest compressions first vs. defibrillation first

Hormone treatment with chemotherapy results in deadly side-effect in neuroblastoma children

'Beach envy' triggers enquiries for liposuction

BioMimetic completes 100 day PMA meeting with FDA for Augment Bone Graft

BC gynecologists initiate campaign to reduce ovarian cancer mortality

Scientists identify molecular marker to analyze chemotherapy response in breast cancer patients

Non-invasive test using patient's breath can detect cancer

Patients expects good long-term solutions for artificial hip system: Report

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

Spirus Medical obtains Japanese marketing approval for ENDO-EASE line of endoscopy devices

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News